Marilyn N. Martinez

TL;DR: This article provides an overview of the patient‐specific and drug‐specific variables that can affect drug absorption following oral product administration and develops formulations that will maximize product availability.

TL;DR: This review focuses on the use of fluoroquinolones within veterinary medicine, providing an overview of the structure-activity relationship of the various members of the group, the clinical uses offluoroquolones in veterinary Medicine, their pharmacokinetics and potential interspecies differences, and a summary of toxicities associated with this class of compounds.

TL;DR: This minireview provides an overview of published evidence supporting the positions that, in most situations, it is the exposure achieved during the first dose that is relevant for determining the therapeutic outcome of an infection and therapeutic intervention should be initiated as soon as possible to minimize the size of the bacterial burden at the infection site.

TL;DR: This paper examines manufacturing and formulation variables that can affect drug bioavailability, and the potential for species-specific differences in the responses to these formulations.